Instructions to Authors

For comprehensive information regarding the journal's policies on submission, peer-review, publication, and ethical standards, kindly visit the Journal Policies. Similarly, for detailed information about the journal, please visit the About Us.

The journal underwent a name change in 2023, and as a result, it appears under two different names in the Web of Science lists. It is listed in the RESPIRATORY SYSTEM category under both its former name, Turkish Thoracic Journal, and its new title, Thoracic Research and Practice. During the associate professorship evaluation, you can present the journal's Q4 ranking by including the visual accessible via the provided link. This situation will also apply for 2024. Once the 2024 Web of Science rankings are calculated, the list’s PDF will be available on our website.

It is strongly advised to review the journal's policies before submitting any manuscripts to ensure compliance with the journal's guidelines.

If you would like to conduct an eligibility check before uploading your article to the journal, you can use the Pre-Submission Check tool. This tool helps you identify and correct any deficiencies in your article.

Manuscripts submitted for evaluation should be original and not previously presented or published in any electronic or print medium. If a manuscript was previously presented at a conference or meeting, authors should provide detailed information about the event, including the name, date, and location of the organization.

Manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (updated in May 2023). 

Authors are required to prepare manuscripts in accordance with the relevant guideline listed below:

•    Randomized research studies and clinical trials: CONSORT guidelines (for protocols, please see the SPIRIT guidance)
•    Observational original research studies: STROBE guidelines 
•    Studies on diagnostic accuracy: STARD guidelines
•    Systematic reviews and meta-analysis: PRISMA guidelines (for protocols, please see the PRISMA-P guidelines)
•    Experimental animal studies: ARRIVE guidelines and Guide for the Care and Use of Laboratory Animals, 8th edition
•    Nonrandomized evaluations of behavioral and public health interventions: TREND guidelines
•    Case report: the CARE case report guidelines
•    Genetic association studies: STREGA
•    Qualitative research: SRQR guidelines

To find the right guideline for your research, please complete the questionnaire by Equator Network here.

Thoracic Research and Practice encourages authors to follow the ‘Sex and Gender Equity in Research – SAGER – guidelines’ when preparing their manuscripts to promote the inclusion of sex and gender considerations in research. Before submission, authors can consult EASE Guidelines for Authors and Translators to produce clear, concise and accurate manuscripts that are easy to understand and free of common errors and pitfalls.

The style of manuscripts should follow the AMA Manual of Style, 11th Edition.

Manuscripts can only be submitted through the journal’s online manuscript submission and evaluation system. Manuscripts submitted via any other medium and submissions by anyone other than one of the authors will not be evaluated.
 
In addition to the manuscript files, authors are required to submit the following during the initial submission:

· Copyright Agreement Form, and
· ICMJE Disclosure Form  (should be filled in by all contributing authors) These forms are available for download at thoracrespract.org. 

Preparation of the Manuscript

Title page: A separate title page should be  submitted with all submissions and this page should include:
•    The full title of the manuscript as well as a short title (running head) of no more than 50 characters,
•    Name(s), affiliations, highest academic degree(s), and ORCID IDs of the author(s),
•    Grant information and detailed information on the other sources of support,
•    Name, address, telephone (including the mobile phone number), and email address of the corresponding author,
•    Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfill the authorship criteria. 
•    If the author(s) is a member of the journal's Editorial Board, this should be specified in the title page.

Abstract: An abstract should be submitted with all submissions except for Letter to the Editor. The abstract of Research Articles and Study Protocols should be structured with subheadings (Objective, Material and Methods, Results, and Conclusion). Please check Table 1 below for word count specifications.
 
Keywords: Keywords should be provided for all submissions except for Letters to the Editor. Each submission must be accompanied by a minimum of three to a maximum of six keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations. The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).
 
Main Points: All submissions except letters to the editor should be accompanied by 3 to 5 “main points.” These main points should highlight the most important results of the study and emphasize the main message of the manuscript. The main points should be structured as a list and should be written in a clear and straightforward manner. Since the main points are intended for experts and specialists in the field, they should be written in plain language that is easy to understand. By including main points with the manuscript, authors can help ensure that the most important findings and messages of their study are conveyed clearly to the reader.

Manuscript Types

Original Articles: Original articles provide new information based on original research. The acceptance of research articles is typically based on the originality and importance of the research. The main text of a Research Article should be structured with subheadings, including Introduction, Material and Methods, Results, and Discussion. 

Limitations, drawbacks, and the shortcomings of original articles should be mentioned in the Discussion section before the conclusion paragraph.

Please check Table 1 for the limitations for Original Articles

Clinical Trials: Thoracic Research and Practice adopts the ICMJE's clinical trial registration policy, which requires that clinical trials must be registered in a publicly accessible registry that is a primary register of the WHO International Trials Registry Platform (ICTRP) or in ClinicalTrials.gov. By registering clinical trials in a publicly accessible registry, authors can help to promote transparency and accountability in their research.
 
Instructions for the clinical trials are listed below.
 
• Clinical trial registry is only required for the prospective research projects that study the relationship between a health-related intervention and an outcome by assigning people to different groups.
• To have their manuscript evaluated in the journal, authors should register their research to a public registry at or before the time of first patient enrollment.
• Based on most up to date ICMJE recommendations, Thoracic Research and Practice accepts public registries that include minimum acceptable 24-item trial registration dataset.
• Authors are required to state a data sharing plan for the clinical trial registration. Please see details under the “Data Sharing” section.
• For further details, please check ICMJE Clinical Trial Policy and COPE Data and Reproducibility guidelines.

Reporting Statistical Analysis

Statistical analysis to support conclusions is usually necessary. Statistical analyses must be conducted in accordance with international statistical reporting standards (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983: 7; 1489-93). Information on statistical analyses should be provided with a separate subheading under the Materials and Methods section and the statistical software that was used during the process must be specified.

When reporting statistical data in a research paper, it is important to present the values in a clear and consistent manner. P values, confidence intervals (CIs), and other statistical measures should be rounded appropriately and expressed according to the guidelines provided. For example, P values should be expressed to two digits to the right of the decimal point unless the first two digits are zeros, in which case three digits should be provided (eg, instead of P < .01, report as P = .002). However, values close to .05 may be reported to three decimal places because .05 is an arbitrary cut-off point for statistical significance (eg,  P = .053). P values less than .001 should be designated as P < .001 rather than providing the exact value (eg, P = .000006). 
 
Units should be prepared in accordance with the International System of Units (SI).


Review Articles: Review articles are generally commissioned by the Editors-in-Chief and are written by authors with extensive knowledge and expertise in a particular field, with a strong track record of publication. Authors may be invited to contribute such reviews to Thoracic Research and Practice.

Unsolicited review articles are not generally considered for publication, and the likelihood of acceptance is low. Authors who still wish to submit an unsolicited review may do so online, accompanied by a cover letter explaining the timeliness and significance of the manuscript. However, these submissions will undergo an initial editorial evaluation and may be declined without external review.

Invited review articles should provide a comprehensive overview of the current state of knowledge on a topic in clinical practice and include discussions and evaluations of relevant research. Subheadings may be planned by the authors; however, each review article must contain an “Introduction” and a “Conclusion” section.

Please check Table 1 for the limitations for Review Articles.

Editorial Comments: Invited editorial comments on selected articles are published in the journal to provide expert insight and critical analysis of the research presented. These comments are written by authors who have demonstrated expertise or a high reputation in the topic of the research article. The journal carefully selects and invites these authors to contribute their comments. The editorial comments should not exceed 1000 words in length and should not include an abstract, keywords, tables, figures, images, or other media.

Letters to the Editor: A "Letter to the Editor" is a type of manuscript that discusses important or overlooked aspects of a previously published article. This type of manuscript may also present articles on subjects within the scope of the journal that are of interest to readers, particularly educational cases. Readers can also use the "Letter to the Editor" format to share their comments on published manuscripts. The text of a "Letter to the Editor" should be unstructured and should not include an abstract, keywords, tables, figures, images, or other media. The manuscript that is being commented on must be properly cited within the "Letter to the Editor."

Research Letter: "Research Letters" are concise reports of original research that highlight new findings or observations in a specific field. They should be a maximum of 600 words in length, with no more than 6 references and 6 authors, and should not include any supplementary material or subsections. Research Letters may include up to 2 tables or figures. Research Letters do not require an abstract or keywords, and do not have to be structured into separate sections. These manuscripts are intended to provide a quick and concise presentation of new research that is of interest to the journal's readership. Please refer to Table 1 for the limitations of Research Letter.

Study Protocol: To promote transparency in research and disseminate ongoing studies, Thoracic Research and Practice accepts study protocols for evaluation. These articles should follow a specific format, including an Abstract, Introduction, Methods (including design, subject selection/treatment, intervention methods, and data analysis), Discussion, and Ethics sections. Study protocols must have ethical approval and registration is required for clinical trials. Only proposed or ongoing research (with specified dates) will be considered for publication, and articles reporting completed studies will not be accepted. Please refer to Table 1 for the limitations of Study Protocol.


Table 1. Limitations for each manuscript type

Type of manuscript

Word limit*

Abstract word limit

Reference limit

Table limit

Figure limit

Research Article

3500

250 (Structured)

30

5

Up to 4 figures (each may include multiple parts, e.g., A-D)

Review Article   

4500

250

150

5

Up to 8 figures (each may include multiple parts)

Study Protocol

3500

250 (Structured)

40

2

2

Research Letter

700

No abstract

10

Maximum 2 tables or figures (combined)

Maximum 2 tables or figures (combined)

Letter to the Editor

400

No abstract

8

No tables

1 figure (optional)

*Word limit refers to the main text only and does not include the abstract, references, tables, figure legends, or supplementary material.

Tables

Tables should be included in the main document, after the reference list, and they should be numbered consecutively in the order they are referred to within the text. Each table should have a descriptive title placed above it, and any abbreviations used in the table should be defined below the table by footnotes (even if they are defined in the main text). Tables should be created using the "insert table" command of the Word processing software, and they should be arranged clearly to make the data easy to read and understand. The data presented in the tables should not be a repetition of the data presented in the main text, but should support and enhance the main text.
 

Figures and Figure Legends

Figures should be submitted as separate files in TIFF or JPEG format, and they should not be embedded in the Word document or the main manuscript file. If a figure has subunits, each subunit should be submitted as a separate file, and the subunits should not be merged into a single image. The figures should not be labeled (a, b, c, etc.) to indicate subunits. Instead, the figure legend should be used to describe the different parts of the figure. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends.Images should be anonymized to remove any information that may identify individuals or institutions. The minimum resolution of each figure should be 300 DPI, and the figures should be clear and easy to read. Figure legends should be listed at the end of the main document. Figures should be referred to within the main text, and they should be numbered consecutively in the order in which they are mentioned. 

Abbreviations

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the definition, and it should be used consistently throughout the paper.

Identifying products

When mentioning a drug, product, hardware, or software program in a manuscript, it is important to provide detailed information about the product in parentheses. This should include the name of the product, the producer of the product, and the city and country of the company. For example, if mentioning a Discovery St PET/CT scanner produced by General Electric in Milwaukee, Wisconsin, USA, the information should be presented in the following format: "Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)." Providing this information helps to ensure that the product is properly identified and credited.

Supplementary Materials

Supplementary materials, including audio files, videos, datasets, and additional documents (e.g., appendices, additional figures, tables), are intended to complement the main text of the manuscript. These supplementary materials should be submitted as a separate section after the references list. Concise descriptions of each supplementary material should be included to explain their relevance to the manuscript. Page numbers are not required for supplementary materials.

Visual Abstract

Starting from May 2025, Thoracic Research and Practice will require a visual abstract for all accepted original research articles. This visual summary aims to enhance the visibility and accessibility of your research across digital platforms. It will be requested only after the manuscript has been accepted, and authors will be granted two weeks to submit it. Please note that your article cannot be assigned to an issue or proceed to publication until the visual abstract has been received.

  • The visual abstract template provided by the journal must be used when preparing your visual summary.

  • The visual abstract should be a clear, self-explanatory image that summarizes the main findings of the study.

  • The image must be submitted in PDF or MS Office files, with a minimum resolution of 300 dpi.

  • Textual elements within the image should be minimal and thoughtfully integrated into the visual itself; avoid overcrowding.

  • Authors are encouraged to use simple illustrations, flow diagrams, or schematic representations to effectively communicate their results.

References

Both in-text citations and the references must be prepared according to the AMA Manual of Style 11th Edition.

When citing publications, preference should be given to the latest, most up-to-date sources. Citing the latest sources can help to ensure that the paper is relevant and timely, and that it reflects the latest developments in the field.

It is the responsibility of the authors to ensure the accuracy of the references in their article. All sources must be properly cited, and the citations must be formatted correctly.

In the main text of the manuscript, references should be cited in superscript after punctuation. 

If an ahead-of-print publication is cited, the DOI number should be provided in the reference list.

Journal titles should be abbreviated in the reference list in accordance with the journal abbreviations in Index Medicus/MEDLINE/PubMed. 

When there are six or fewer authors, all authors should be listed. If there are seven or more authors, the first three authors should be listed followed by “et al.” in the reference list. 

The reference styles for different types of publications are presented in the following examples.
 
Journal Article: Ammitzboll C, Andersen JB, Vils SR, et al. Isolation, behavioral changes, and low seroprevalence of SARS-CoV-2 antibodies in patients with systemic lupus erythematosus or rheumatoid arthritis. Arthritis Care Res. 2022;74(11):1780-1785.

Book Section: Cohen EL. The multidisciplinary, interdisciplinary, and transdisciplinary nature of health communication scholarship. In: Thompson TL, Harrington NG, eds. The Routledge Handbook of Health Communication. London: Routledge;2022:3-16.

Books with a Single Author: Haslwanter T. An Introduction to Statistics with Python. 2nd ed. New York, NY: Springer International Publishing; 2022.

Editor(s) as Author: Thompson TL, Harrington NG, eds. The Routledge Handbook of Health Communication. London: Routledge;2022.

Thesis: Chunga A. The Role of the Gastrointestinal Tract Microbiota in Colonisation Resistance Against Common Enteric Pathogens in Malawian Children. Dissertation. University of Liverpool; 2022.

Websites:  International Society for Infectious Diseases. ProMed-mail. Accessed December 13, 2022. http://www.promedmail.org 

Epub Ahead of Print Articles: Torres X, Bennasar M, Bautista-Rodríguez C, et al. The heart after surviving twin-to-twin transfusion syndrome. Am J Obstet Gynecol. 2022 Mar 26. doi: 10.1016/j.ajog.2022.03.049. [Epub ahead of print].

Production Processes

Language Editing

Once a manuscript has been accepted for publication, the language editing service of Thoracic Research and Practice is provided by Galenos Publishing House to ensure that it is clear and well-written. This process may involve correcting grammar, punctuation, and formatting errors, as well as making changes to improve the overall clarity and readability of the manuscript.

Use of Large Language Models and Generative AI Tools

 AI tools cannot meet the requirements for authorship as they cannot take responsibility for the submitted work. As non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements. Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.” COPE Position Statement on Authorship and AI tools. Detailed information about the statement can be accessed at https://publicationethics.org/cope-position-statements/ai-author

 After reviewing the COPE statement, the editors of the Thoracic Research and Practice have decided that papers should include a statement in a section called “Declaration Regarding the Use of AI and AI-Assisted Technologies” to let readers know if AI or AI-assisted tools were used in the writing process. It's important to remember that all authors are responsible for the content of their work. This declaration does not apply to the use of basic tools for checking grammar, spelling, or references (such as Mendeley, EndNote, Zotero, and others). If there is nothing to declare, there is no need to add a statement.

 It is suggested that authors follow this format when preparing their statement:

 During the preparation of this work, the author(s) utilized [NAME OF TOOL(S) USED] to [DESCRIPTION OF HOW THE TOOL(S) WERE UTILIZED AND HOW THE VALIDITY OF THE OUTPUTS WAS EVALUATED]. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted [SPECIFY WHICH ASPECTS OF THE STUDY, ARTICLE CONTENTS, DATA, OR SUPPORTING FILES WERE AFFECTED/GENERATED].

 Example:

During the preparation of this work, the author(s) utilized OpenAI's ChatGPT to generate summaries of research articles related to the topic. These summaries were evaluated by comparing them to manually written summaries by experts in the field. Upon confirming the accuracy and relevance of the generated summaries, they were integrated into the literature review section of the manuscript. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted the efficiency of literature review process and the comprehensiveness of the gathered research insights.

Proof Production

After the copy-editing process is complete, the manuscript is published online as an "ahead-of-print" publication, which means that it is available to readers before it is included in a scheduled issue of the journal. This allows readers to access the latest research as soon as it becomes available.

When the PDF of the article is generated, the corresponding author will receive an email with a link to our online proofing system. With that email, the author can make corrections to the article.

The corresponding author is asked to review the proof and approve it for publication within a specified time period, typically two days. 

Web-based proofing provides a faster and more accurate process by allowing you to type your corrections directly, eliminating the potential introduction of errors. Please use this proof only for checking the typesetting, editing, completeness, and correctness of the text, tables, and figures. Since the article is in the pre-publication process, significant changes will only be implemented with the editorial decision.